{{Rsnum
|rsid=12518099
|Chromosome=5
|position=90250292
|Orientation=plus
|GMAF=0.2934
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LINC01339
|Gene_s=LINC01339
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.1 | 31.9 | 7.1
| HCB | 40.9 | 40.9 | 18.2
| JPT | 34.5 | 40.7 | 24.8
| YRI | 61.2 | 31.3 | 7.5
| ASW | 59.6 | 36.8 | 3.5
| CHB | 40.9 | 40.9 | 18.2
| CHD | 41.3 | 45.9 | 12.8
| GIH | 43.6 | 51.5 | 5.0
| LWK | 64.5 | 30.0 | 5.5
| MEX | 58.6 | 32.8 | 8.6
| MKK | 68.6 | 25.6 | 5.8
| TSI | 48.0 | 43.1 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19734900
|Trait=Type 2 diabetes and other traits
|Title=Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia
|RiskAllele=C
|Pval=7E-7
|OR=1.16
|ORtxt=[1.10-1.22]
}}

{{PMID|22237986|OA=1
}} Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12518099
|overall_frequency_n=38
|overall_frequency_d=128
|overall_frequency=0.296875
|n_genomes=28
|n_genomes_annotated=0
|n_haplomes=35
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}